To investigate the impact of B2M depletion and HLA-E expression on CAR T-cell antitumor activity28, we first determined whether CAR T cells engineered with these changes showed cytotoxic activity against leukemia cell lines in vitro. This evidence concerns the gene HLA-E and leukemia.